Oncology Institute, Inc. (TOI) Non-Current Deffered Revenue (2020 - 2021)

Oncology Institute (TOI) has 2 years of Non-Current Deffered Revenue data on file, last reported at $6.3 million in Q3 2021.

• Quarterly Non-Current Deffered Revenue changed 0.0% year-over-year to $6.3 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $6.3 million (changed 0.0% YoY) and the FY2020 annual result came in at $6.3 million, changed N/A from the prior year.
• Non-Current Deffered Revenue steadied at $6.3 million in Q3 2021, from $6.3 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $6.3 million in Q1 2020 to a low of $6.3 million in Q1 2020.